A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity. (Q51756006)

11 April 2018

title

A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity. (English)

1 reference

11 April 2018

author

Philippe Charron

6

1 reference

11 April 2018

Richard Isnard

9

1 reference

11 April 2018

Laurent Gouya

10

1 reference

11 April 2018

Gisèle Bonne

14

1 reference

11 April 2018

Felix W Friedrich

Felix W Friedrich

1

0 references

Pascale Richard

Pascale Richard

11

0 references

Jean-Thomas Vilquin

Jean-Thomas Vilquin

8

0 references

Eric Villard

Eric Villard

17

0 references

Michel Komajda

13

Michel Komajda

1 reference

11 April 2018

2

Gilles Dilanian

1 reference

11 April 2018

Véronique Fressart

7

Véronique Fressart

1 reference

11 April 2018

author name string

Patricia Khattar

3

1 reference

11 April 2018

Denise Juhr

4

1 reference

11 April 2018

Lucie Gueneau

5

1 reference

11 April 2018

Naima Hammoudi

12

1 reference

11 April 2018

Thomas Eschenhagen

15

1 reference

11 April 2018

Olivier Dubourg

16

1 reference

11 April 2018

Lucie Carrier

18

1 reference

11 April 2018

publication date

14 November 2012

1 reference

11 April 2018

European Journal of Heart Failure

published in

1 reference

11 April 2018

volume

15

1 reference

11 April 2018

page(s)

267-276

1 reference

11 April 2018

issue

3

1 reference

11 April 2018

Biology of Isl1+ cardiac progenitor cells in development and disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Localization of Islet-1-positive cells in the healthy and infarcted adult murine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Distinction between two populations of islet-1-positive cells in hearts of different murine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Foxh1 is essential for development of the anterior heart field

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Common variation in ISL1 confers genetic susceptibility for human congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Genetics of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Truncations of titin causing dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Guidelines for the diagnosis and management of familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Emery-Dreifuss muscular dystrophy - a 40 year retrospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

"Laminopathies": a wide spectrum of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

82nd ENMC international workshop, 5th international Emery-Dreifuss muscular dystrophy (EDMD) workshop, 1st Workshop of the MYO-CLUSTER project EUROMEN (European muscle envelope nucleopathies), 15-16 September 2000, Naarden, The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Common vs. rare allele hypotheses for complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Human genetic variation and its contribution to complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Positional candidate gene analysis of Lim domain homeobox gene (Isl-1) on chromosome 5q11-q13 in a French morbidly obese population suggests indication for association with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Transcription factor cascades in congenital heart malformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Beta-catenin directly regulates Islet1 expression in cardiovascular progenitors and is required for multiple aspects of cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Islet1-mediated activation of the β-catenin pathway is necessary for hindlimb initiation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Cardiac-specific haploinsufficiency of beta-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS178

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFS178

1 reference

11 April 2018

PubMed ID

23152444

1 reference

11 April 2018